Active, not recruitingNot applicableNCT02601417
The Necessity of Bile Cultures in Patients With Acute Cholangitis
Studying Sclerosing cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Seoul National University Hospital
- Principal Investigator
- Sang Hyub Lee, MD. PhD.Department of internal medicine and liver research institute, Seoul national university hospital, Seoul, Korea
- Intervention
- Ignoring result of bile culture(other)
- Enrollment
- 440 target
- Eligibility
- 20 years · All sexes
- Timeline
- 2015 – 2024
Study locations (1)
- Seoul National University Hospital, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02601417 on ClinicalTrials.govOther trials for Sclerosing cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07317193DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASEFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGPHASE1NCT06825559Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver DiseaseZydus Therapeutics Inc.
- RECRUITINGNCT06781242Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic CholestasisIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGNCT02545309Secondary Sclerosing Cholangitis in Critically Ill PatientsMedical University of Graz